Skip to main content
Advertisement
Menu
Search
Search
Publisher main menu




Journals
Submissions
Publishing services
About
My Account
Follow BioMed Central


Twitter
Facebook
Retrovirology
Retrovirology main menu



Home
About
Articles
Articles


Recent
Most accessed
Recent articles
Recent articles RSS
1. Research
Human endogenous retrovirus (HERV) expression is not induced by
treatment with the histone deacetylase (HDAC) inhibitors in cellular
models of HIV-1 latency
Tara Hurst, Matthew Pace, Aris Katzourakis, Rodney Phillips, Paul Klenerman, John
Frater and Gkikas Magiorkinis
Published on: 6 February 2016
2. Research
Genetic Evolution during the development of an attenuated EIAV vaccine
Xue-Feng Wang, Yue-Zhi Lin, Qiang Li, Qiang Liu, Wei-Wei Zhao, Cheng Du, Jie
Chen, Xiaojun Wang and Jian-Hua Zhou
Published on: 3 February 2016
3. Research
Mechanisms of escape from the PGT128 family of anti-HIV broadly
neutralizing antibodies
Stefanie A. Krumm, Hajer Mohammed, Khoa M. Le, Max Crispin, Terri Wrin, Pascal
Poignard, Dennis R. Burton and Katie J. Doores
Published on: 2 February 2016
4. Research
Classification and characterization of human endogenous retroviruses;
mosaic forms are common
Laura Vargiu, Patricia Rodriguez-Tomé, Göran O. Sperber, Marta Cadeddu, Nicole
Grandi, Vidar Blikstad, Enzo Tramontano and Jonas Blomberg
Published on: 22 January 2016
5. Short report
Identification and spontaneous immune targeting of an endogenous
retrovirus K envelope protein in the Indian rhesus macaque model of
human disease
Helen L. Wu, Enrique J. Léon, Lyle T. Wallace, Francesca A. Nimiyongskul, Matthew B.
Buechler, Laura P. Newman, Philip A. Castrovinci, R. Paul Johnson, Robert J. Gifford,
R. Brad Jones and Jonah B. Sacha
Published on: 15 January 2016
View all articles
Most accessed articles
Most accessed articles RSS
1. Review
Can immunotherapy be useful as a “functional cure” for infection with
Human Immunodeficiency Virus-1?
Guido Vanham and Ellen Van Gulck
Published on: 7 September 2012
2. Review
HIV-1 transcription and latency: an update
Carine Van Lint, Sophie Bouchat and Alessandro Marcello
Published on: 26 June 2013
3. Research
Differential inhibition of LINE1 and LINE2 retrotransposition by
vertebrate AID/APOBEC proteins
Nataša Lindič, Maruška Budič, Toni Petan, Binyamin A Knisbacher, Erez Y Levanon
and Nika Lovšin
Published on: 17 December 2013
4. Short report
A novel acute HIV infection staging system based on 4th generation
immunoassay
Jintanat Ananworanich, James LK Fletcher, Suteeraporn Pinyakorn, Frits van Griensven,
Claire Vandergeeten, Alexandra Schuetz, Tippawan Pankam, Rapee Trichavaroj, Siriwat
Akapirat, Nitiya Chomchey, Praphan Phanuphak, Nicolas Chomont, Nelson L Michael,
Jerome H Kim and Mark de Souza
Published on: 29 May 2013
5. Research
Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs
that prevent hypusination of eukaryotic initiation factor 5A
Mainul Hoque, Hartmut M Hanauske-Abel, Paul Palumbo, Deepti Saxena, Darlene
D'Alliessi Gandolfi, Myung Hee Park, Tsafi Pe'ery and Michael B Mathews
Published on: 13 October 2009
View all articles
Editors-in-Chief
Andrew Lever, University of Cambridge, UK
Mark Wainberg, McGill University AIDS Centre and Jewish General Hospital, Canada
Founding Editor
Kuan-Teh Jeang, National Institutes of Health, USA
Aims and scope
Retrovirology is an open access, online journal that publishes stringently peer-reviewed, highimpact articles on basic retrovirus research. Retroviruses are pleiotropically found in animals.
Well-described examples include avian, murine and primate retroviruses. Two human
retroviruses are especially important pathogens. These are the human immunodeficiency virus,
HIV, and the human T-cell leukemia virus, HTLV. HIV causes AIDS while HTLV-I is the
etiological agent for adult T-cell leukemia. Retrovirology intends to cover these areas of human
and animal retrovirus research.
Tweets
Editor Profiles
Andrew Lever graduated in Biochemistry and Medicine from the University of Wales and
undertook postgraduate training in clinical medicine there and in London and Newcastle. He
took a Doctorate in Immunology studying patients with immunodeficiency at the MRC Clinical
Research Centre in London and further developed his interests in the balance between infectious
agents and the immune system with a Lectureship funded by the Wellcome Trust at the Royal
Free Hospital in London studying viral hepatitis and cytomegalovirus infection. His research on
HIV began in Boston with Dr Joe Sodroski where he began work on studying the mechanism of
RNA encapsidation of retroviruses. He returned to a Senior Lecturer post at St George’s
Hospital, London and moved subsequently to the University of Cambridge, where he was
awarded a Personal Chair in Infectious Diseases in 2000. His research on retroviruses involves
studies of the biology and fate of the genomic RNA in lentiviruses and allied work on lentivirusbased vectors and HIV latency, subjects which are core to Retrovirology.
Mark A. Wainberg is Director of the McGill University AIDS Centre and Professor of
Medicine and of Microbiology at McGill University in Montreal, Canada. Dr. Wainberg is an
internationally recognized scientist in the field of HIV/AIDS, who has made important
independent contributions to the study of anti-viral drug development, HIV drug resistance, and
HIV replication. He served as President of the International AIDS Society between 1998-2000.
He is well known for his initial identification of 3TC as an anti-viral drug, in collaboration with
BioChem Pharma Inc, in 1989. His laboratory continues to work in the above areas and, as well,
Dr. Wainberg has now turned his attention to novel concepts in HIV vaccine development and
prevention of HIV infection. He is a strong advocate of measures that will enhance prevention of
HIV infection in developing countries. He was the Co-Chair of the XVI International AIDS
Conference that took place in Toronto during the summer of 2006.
Submit a manuscript




Submission Guidelines
Editorial Board
Sign up to article alerts
Impact Factor: 4.19
Follow

Follow us on Twitter
ISSN:
1742-4690
Advertisement



Contact us
Jobs
Manage manuscripts



Sign up for article alerts
Manage article alerts
Leave feedback


Press center
Read more on our blogs






Policies
Licensing
Terms and conditions
Privacy statement
Accessibility
Cookies
Follow BioMed Central







Twitter
Facebook
Google Plus
YouTube
LinkedIn
Reddit
Weibo
© 2016 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.
By continuing to use this website, you agree to our Terms and Conditions, Privacy statement and
Cookies policy.